JP Stock MarketDetailed Quotes

4893 Noile-Immune Biotech

Watchlist

131
+2+1.55%

20min DelayMarket Closed May 31 15:00 JST

5.67BMarket Cap-4807P/E (Static)

Noile-Immune Biotech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(FY)Dec 31, 2021

(FY)Dec 31, 2020

Total revenue

-68.07%2.59M

-49.37%316.82M

-50.23%2.67M

302.8M

3.24M

8.1M

521.24%625.78M

5.37M

3.55%100.73M

97.28M

Cost of revenue

-81.39%195K

-68.11%2.26M

164K

258K

787K

1.05M

-69.09%7.08M

671.01%22.9M

2.97M

Gross profit

-66.09%2.39M

-49.16%314.56M

2.51M

302.54M

2.46M

7.05M

694.91%618.71M

-17.47%77.83M

94.31M

Operating expense

23.52%341.68M

50.33%1.09B

-38.42%282.04M

316.9M

214.4M

276.61M

-14.23%725.05M

457.99M

20.97%845.34M

698.78M

Selling and administrative expenses

44.35%147.36M

13.58%443.25M

-65.90%131.35M

--107.69M

--102.13M

--102.08M

18.07%390.25M

--385.16M

15.68%330.52M

--285.72M

-General and administrative expense

44.35%147.36M

13.58%443.25M

--131.35M

--107.69M

--102.13M

--102.08M

18.07%390.25M

----

15.68%330.52M

--285.72M

Research and development costs

11.34%194.32M

93.16%646.71M

106.91%150.69M

--209.22M

--112.28M

--174.52M

-34.97%334.8M

--72.83M

24.64%514.83M

--413.06M

Operating profit

-25.87%-339.28M

-629.13%-775.39M

39.19%-279.53M

-14.36M

-211.94M

-269.56M

86.14%-106.35M

-459.7M

-26.97%-767.51M

-604.48M

Net non-operating interest income (expenses)

27.27%28K

-20.00%44K

22K

-31.25%55K

-97.94%80K

3.88M

Non-operating interest income

27.27%28K

-20.00%44K

--0

--22K

--0

--22K

-31.25%55K

--0

-97.94%80K

--3.88M

Net investment income

-139.04%-310K

-99.91%5K

-88.02%550K

83K

-1.42M

794K

5.48M

4.59M

-484K

Gain(Loss) on financial instruments designated as cash flow hedges

Gain(Loss) on derecognition of available-for-sale financial assets

Income from associates and other participating interests

Special income (charges)

-26.36M

Less:Write off

----

--0

--26.36M

Other non-operating income (expenses)

-24.30%-352.25M

-2.02M

-125.19M

-225.05M

-1,025.32%-283.39M

-265.81M

-613.20%-25.18M

-3.53M

Income before tax

31.23%-339.57M

-193.49%-1.13B

33.41%-278.98M

-16.27M

-338.55M

-493.79M

51.53%-384.2M

-418.94M

-25.62%-792.62M

-630.97M

Income tax

0.16%609K

0.00%2.42M

0.00%599K

608K

605K

608K

0.00%2.42M

599K

-57.36%2.42M

5.68M

Net income

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

-16.88M

-339.16M

-494.4M

51.37%-386.62M

-419.54M

-24.88%-795.04M

-636.65M

Net income continuous operations

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

---16.88M

---339.16M

---494.4M

51.37%-386.62M

---419.54M

-24.88%-795.04M

---636.65M

Noncontrolling interests

Net income attributable to the company

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

-16.88M

-339.16M

-494.4M

51.37%-386.62M

-419.54M

-24.88%-795.04M

-636.65M

Preferred stock dividends

Other under preferred stock dividend

Net income attributable to common stockholders

31.19%-340.18M

-192.28%-1.13B

33.36%-279.58M

-16.88M

-339.16M

-494.4M

51.37%-386.62M

-419.54M

-24.88%-795.04M

-636.65M

Gross dividend payment

Basic earnings per share

37.07%-7.86

-176.06%-27.25

39.76%-6.44

0.22

-8.54

-12.49

48.95%-9.8709

-10.6899

-24.88%-19.3347

-15.4828

Diluted earnings per share

37.07%-7.86

-176.06%-27.25

39.57%-6.4603

-0.39

-8.54

-12.49

48.95%-9.8709

-10.6899

-24.88%-19.3347

-15.4828

Dividend per share

Currency Unit

JPY

Accounting Standards

NonUS-GAAP

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(FY)Dec 31, 2021	(FY)Dec 31, 2020
Total revenue	-68.07%2.59M	-49.37%316.82M	-50.23%2.67M	302.8M	3.24M	8.1M	521.24%625.78M	5.37M	3.55%100.73M	97.28M
Cost of revenue	-81.39%195K	-68.11%2.26M	164K	258K	787K	1.05M	-69.09%7.08M		671.01%22.9M	2.97M
Gross profit	-66.09%2.39M	-49.16%314.56M	2.51M	302.54M	2.46M	7.05M	694.91%618.71M		-17.47%77.83M	94.31M
Operating expense	23.52%341.68M	50.33%1.09B	-38.42%282.04M	316.9M	214.4M	276.61M	-14.23%725.05M	457.99M	20.97%845.34M	698.78M
Selling and administrative expenses	44.35%147.36M	13.58%443.25M	-65.90%131.35M	--107.69M	--102.13M	--102.08M	18.07%390.25M	--385.16M	15.68%330.52M	--285.72M
-General and administrative expense	44.35%147.36M	13.58%443.25M	--131.35M	--107.69M	--102.13M	--102.08M	18.07%390.25M	----	15.68%330.52M	--285.72M
Research and development costs	11.34%194.32M	93.16%646.71M	106.91%150.69M	--209.22M	--112.28M	--174.52M	-34.97%334.8M	--72.83M	24.64%514.83M	--413.06M
Operating profit	-25.87%-339.28M	-629.13%-775.39M	39.19%-279.53M	-14.36M	-211.94M	-269.56M	86.14%-106.35M	-459.7M	-26.97%-767.51M	-604.48M
Net non-operating interest income (expenses)	27.27%28K	-20.00%44K	0	22K	0	22K	-31.25%55K	0	-97.94%80K	3.88M
Non-operating interest income	27.27%28K	-20.00%44K	--0	--22K	--0	--22K	-31.25%55K	--0	-97.94%80K	--3.88M
Net investment income	-139.04%-310K	-99.91%5K	-88.02%550K	83K	-1.42M	794K	5.48M	4.59M		-484K
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
Income from associates and other participating interests
Special income (charges)									0	-26.36M
Less:Write off	----	----	----	----	----	----	----	----	--0	--26.36M
Other non-operating income (expenses)		-24.30%-352.25M	0	-2.02M	-125.19M	-225.05M	-1,025.32%-283.39M	-265.81M	-613.20%-25.18M	-3.53M
Income before tax	31.23%-339.57M	-193.49%-1.13B	33.41%-278.98M	-16.27M	-338.55M	-493.79M	51.53%-384.2M	-418.94M	-25.62%-792.62M	-630.97M
Income tax	0.16%609K	0.00%2.42M	0.00%599K	608K	605K	608K	0.00%2.42M	599K	-57.36%2.42M	5.68M
Net income	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	-16.88M	-339.16M	-494.4M	51.37%-386.62M	-419.54M	-24.88%-795.04M	-636.65M
Net income continuous operations	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	---16.88M	---339.16M	---494.4M	51.37%-386.62M	---419.54M	-24.88%-795.04M	---636.65M
Noncontrolling interests
Net income attributable to the company	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	-16.88M	-339.16M	-494.4M	51.37%-386.62M	-419.54M	-24.88%-795.04M	-636.65M
Preferred stock dividends
Other under preferred stock dividend	0	0	0	0	0	0	0	0	0	0
Net income attributable to common stockholders	31.19%-340.18M	-192.28%-1.13B	33.36%-279.58M	-16.88M	-339.16M	-494.4M	51.37%-386.62M	-419.54M	-24.88%-795.04M	-636.65M
Gross dividend payment
Basic earnings per share	37.07%-7.86	-176.06%-27.25	39.76%-6.44	0.22	-8.54	-12.49	48.95%-9.8709	-10.6899	-24.88%-19.3347	-15.4828
Diluted earnings per share	37.07%-7.86	-176.06%-27.25	39.57%-6.4603	-0.39	-8.54	-12.49	48.95%-9.8709	-10.6899	-24.88%-19.3347	-15.4828
Dividend per share
Currency Unit	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY	JPY
Accounting Standards	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP	NonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall